BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 1672481)

  • 1. Comparison of celiprolol and propranolol in stable angina pectoris. Celiprolol International Angina Study Group.
    Frishman WH; Heiman M; Soberman J; Greenberg S; Eff J
    Am J Cardiol; 1991 Apr; 67(8):665-70. PubMed ID: 1672481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Double-blind, placebo-controlled trial of propranolol vs celiprolol in stable effort angina: antianginal efficacy and side effects ].
    Klein W; Fluch N; Brandt D
    Wien Klin Wochenschr; 1982 May; 94(10):258-61. PubMed ID: 6126961
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Celiprolol in the treatment of exercise induced angina pectoris.
    Capone P; Mayol R
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S135-7. PubMed ID: 2427844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atenolol and celiprolol for stable angina pectoris.
    McLenachan JM; Findlay IN; Henderson E; Wilson JT; Dargie HJ
    Am J Cardiol; 1988 Feb; 61(5):52C. PubMed ID: 2893533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    Am Heart J; 1988 Nov; 116(5 Pt 2):1422-5. PubMed ID: 2903653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angina pectoris: effective therapy once daily.
    Prager G
    J Int Med Res; 1979; 7(1):39-44. PubMed ID: 33863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of oral propranolol and verapamil for combined systemic hypertension and angina pectoris. A placebo-controlled double-blind randomized crossover trial.
    Frishman WH; Klein NA; Klein P; Strom JA; Tawil R; Strair R; Wong B; Roth S; LeJemtel TH; Pollack S; Sonnenblick EH
    Am J Cardiol; 1982 Nov; 50(5):1164-72. PubMed ID: 6127946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti-ischemic effects of celiprolol in patients with exercise-induced angina pectoris.
    Douard H; Koch M; Laporte T; Abella ML; Provendier O; Broustet JP
    Int J Cardiol; 1989 Oct; 25(1):63-8. PubMed ID: 2571590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Celiprolol and atenolol in angina--effects on left ventricular function.
    Dargie H; McLenachan JM; Wilson JT
    J Int Med Res; 1988; 16 Suppl 1():47A-51A. PubMed ID: 2906017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antianginal efficacy and improved exercise performance with timolol. Twice-daily beta blockade in ischemic heart disease.
    Harris FJ; Low RI; Paumer L; Amsterdam EA; Mason DT
    Am J Cardiol; 1983 Jan; 51(1):13-8. PubMed ID: 6129794
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Celiprolol in angina pectoris: a controlled study.
    Eff J; Godfrey J; Garutti R; Capone P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 4():S132-4. PubMed ID: 2427843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of ancillary properties of beta blockers in angina: a study of celiprolol and atenolol.
    McLenachan JM; Wilson JT; Dargie HJ
    Br Heart J; 1988 Jun; 59(6):685-9. PubMed ID: 2899439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double-blind comparison of tolamolol, propranolol, practolol, and placebo in the treatment of angina pectoris.
    Jackson G; Atkinson L; Oram S
    Br Med J; 1975 Mar; 1(5960):708-12. PubMed ID: 804952
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the new beta-adrenoceptor antagonist, nadolol, and propranolol in the treatment of angina pectoris.
    Furberg B; Dahlqvist A; Raak A; Wrege U
    Curr Med Res Opin; 1978; 5(5):388-93. PubMed ID: 26520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-anginal and anti-ischemic effects of the selective beta-blocker talinolol in patients with stable angina pectoris.
    Faulhaber HD; Weigmann I; Lang U; Weinsberg F; Terhaag B
    Int J Clin Pharmacol Ther; 2005 Feb; 43(2):63-70. PubMed ID: 15726874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical performance and therapeutic potential of celiprolol in angina pectoris.
    Soberman JE; Frishman WH
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S9-13. PubMed ID: 2481791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of atenolol with propranolol in the treatment of angina pectoris with special reference to once daily administration of atenolol.
    Jackson G; Harry JD; Robinson C; Kitson D; Jewitt DE
    Br Heart J; 1978 Sep; 40(9):998-1004. PubMed ID: 101223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiprolol vs propranolol in unstable angina pectoris: a double-blind, randomized, parallel-group study.
    Cleophas TJ; van 't Leven M; Kauw FH; Remmert HP; Kuijper A; Zwinderman K
    Angiology; 1995 Feb; 46(2):137-44. PubMed ID: 7702198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical evaluation of bisoprolol in patients with stable angina pectoris: a preliminary report.
    Kato K; Niitani H; Kanazawa T; Shimomura K; Toyama S
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S154-9. PubMed ID: 2439788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative effects of long-acting and conventional propranolol on stress-induced angina pectoris and on frequency of ventricular premature beats.
    Hansteen V; Endresen K; Hellemann H; Eriksen II; Brorssen O; Ekeli T; Day M; Baber NS
    Br J Clin Pharmacol; 1984 May; 17(5):579-84. PubMed ID: 6203546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.